Amicus Therapeutics
Trade Amicus Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About FOLD
Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.
FOLD Key Statistics
Stock Snapshot
Amicus Therapeutics(FOLD) stock is priced at $14.31, giving the company a market capitalization of 4.5B. It carries a P/E multiple of -320.13.
As of 2026-02-14, Amicus Therapeutics(FOLD) stock has fluctuated between $14.30 and $14.35. The current price stands at $14.31, placing the stock +0.1% above today's low and -0.3% off the high.
The Amicus Therapeutics(FOLD)'s current trading volume is 6.98M, compared to an average daily volume of 8.01M.
In the last year, Amicus Therapeutics(FOLD) shares hit a 52-week high of $14.38 and a 52-week low of $5.51.
In the last year, Amicus Therapeutics(FOLD) shares hit a 52-week high of $14.38 and a 52-week low of $5.51.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.